Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Antiviral Research|June 2, 2009
Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1Alessandro Ascione, Barbara Capecchi, Laura Campitelli, et al.
Journal of Virology|December 31, 2010
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccinesSilvia Loureiro, Junyuan Ren, Pongsathon Phapugrangkul, et al.
Plos Pathogens|December 3, 2024
Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell linesKimberley C Siwak, Emmanuelle V LeBlanc, Heidi M Scott, et al.
Frontiers in Immunology|May 3, 2024
Mapping the interaction sites of human and avian influenza A viruses and complement factor HIman Rabeeah, Elizabeth Billington, Béatrice Nal, et al.
Virology|October 19, 2010
Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssavirusesEdward Wright, David T S Hayman, Aisling Vaughan, et al.
Frontiers in Immunology|February 28, 2022
AutoPlate: Rapid Dose-Response Curve Analysis for Biological AssaysPhil Palmer, Joanne Marie M Del Rosario, Kelly A S da Costa, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodiesNigel J Temperton, Katja Hoschler, Diane Major, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionVamsee V A Mallajosyula, Michael Citron, Francesca Ferrara, et al.
Vaccines|September 23, 2022
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine DesignKelly A S da Costa, Joanne Marie M Del Rosario, Matteo Ferrari, et al.
European Journal of Immunology|April 17, 2013
Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccineCaitlin E Mullarkey, Amy Boyd, Arjan van Laarhoven, et al.
Pageof 5